Group 1 - MAIA Biotechnology, Inc. has a Zacks Rank 1 with a 44.4% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - MAIA's shares gained 0.5% over the last three months, while the S&P 500 declined by 5.6% [1] - MAIA possesses a Momentum Score of A [1] Group 2 - Byrna Technologies Inc. has a Zacks Rank 1 with a nearly 25% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Byrna's shares gained 33.8% over the last six months, compared to the S&P 500's decline of 4.7% [2] - Byrna possesses a Momentum Score of B [2] Group 3 - OncoCyte Corporation has a Zacks Rank 1 with a 39.3% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [3] - OncoCyte's shares gained 45.3% over the last three months, while the S&P 500 declined by 5.6% [3] - OncoCyte possesses a Momentum Score of B [3]
Best Momentum Stocks to Buy for May 6th